...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

ATTENTION MEMBERS: 

Tonight, we're giving our website a serious makeover.  

So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.  

In the event that you experience issues accessing the new site, please clear your browser's cookies and cache. 

See You On The Other Side!

Message: Re: EDITRe: i would love to hear,..
1
Dec 06, 2019 08:42AM
1
Dec 06, 2019 08:44AM
2
Dec 06, 2019 08:52AM
3
Dec 06, 2019 09:01AM

BDAZ

"I'm impressed. In diabetic, recent ACS patients 70 years or older w/ baseline MoCA <22, apabetalone elicited a statistically significant 158% increase in MoCA vs. placebo in BETonMACE cognition sub-study."

So 158% vs placebo. Perhaps it is obvious but I'm not a scientist. Question I have is did this actually improve MoCA vs baseline? Ie did these brain functions increase or did they not deteriorate as much?

Sorry to ask if the answer is obvious. Thanks

Toinv

Share
New Message
Please login to post a reply